Bioconjugate Chemistry
Article
(2) Reddy, J. A., Dorton, R., Westrick, E., Dawson, A., Smith, T., Xu,
L. C., Vetzel, M., Kleindl, P., Vlahov, I. R., and Leamon, C. P. (2007)
Preclinical evaluation of EC145, a folate-vinca alkaloid conjugate.
Cancer Res. 67, 4434−42.
(3) Vlahov, I. R., Santhapuram, H. K., Kleindl, P. J., Howard, S. J.,
Stanford, K. M., and Leamon, C. P. (2006) Design and regioselective
synthesis of a new generation of targeted chemotherapeutics. Part 1:
EC145, a folic acid conjugate of desacetylvinblastine monohydrazide.
Bioorg. Med. Chem. Lett. 16, 5093−6.
(19) Leamon, C. P., Reddy, J. A., Dorton, R., Bloomfield, A.,
Emsweller, K., Parker, N., and Westrick, E. (2008) Impact of high and
low folate diets on tissue folate receptor levels and antitumor
responses toward folate-drug conjugates. J. Pharmacol. Exp. Ther. 327,
918−25.
(20) Leamon, C. P., and Low, P. S. (1991) Delivery of
macromolecules into living cells: a method that exploits folate
receptor endocytosis. Proc. Natl. Acad. Sci. U.S.A. 88, 5572−6.
(4) Parker, N., Turk, M. J., Westrick, E., Lewis, J. D., Low, P. S., and
Leamon, C. P. (2005) Folate receptor expression in carcinomas and
normal tissues determined by a quantitative radioligand binding assay.
Anal. Biochem. 338, 284−93.
(5) Ross, J. F., Chaudhuri, P. K., and Ratnam, M. (1994) Differential
regulation of folate receptor isoforms in normal and malignant tissues
in vivo and in established cell lines. Physiologic and clinical
implications. Cancer 73, 2432−43.
(6) Toffoli, G., Cernigoi, C., Russo, A., Gallo, A., Bagnoli, M., and
Boiocchi, M. (1997) Overexpression of folate binding protein in
ovarian cancers. Int. J. Cancer 74, 193−198.
(7) Weitman, S. D., Lark, R. H., Coney, L. R., Fort, D. W., Frasca, V.,
Zurawski, V. R., and Kamen, B. A. (1992) Distribution of the folate
receptor GP38 in normal and malignant cell lines and tissues. Cancer
Res. 52, 3396−3401.
(8) Edelman, M. J., Harb, W. A., Pal, S. E., Boccia, R. V., Kraut, M. J.,
Bonomi, P., Conley, B. A., Rogers, J. S., Messmann, R. A., and Garon,
E. B. (2012) Multicenter trial of EC145 in advanced, folate-receptor
positive adenocarcinoma of the lung. Journal of thoracic oncology:
official publication of the International Association for the Study of Lung
Cancer 7, 1618−21.
(9) Naumann, R. W., Morris, R., Harb, W., Micha, J., Sutton, G.,
Dinh, T., Mcintyre, J., Patel, R., Davidson, J., Hu, E., and Messmann,
R. (2009) Abstract 1181 In 16th International Meeting of the European
Society for Gynecological Oncology.
(10) Naumann, R. W., Coleman, R. L., Burger, R. A., Herzog, T. J.,
Morris, R., Sausville, E. A., Kutarska, E., Ghamande, S. A., Gabrail, N.
Y., De Pasquale, S., Nowara, E., Gilbert, L., Caton, J. R., Gersh, R. H.,
Teneriello, M. G., Harb, W. A., Konstantinopoulos, P., Symanowski, J.
T., Lovejoy, C., and Messmann, R. A. (2011) J. Clin. Oncol. 29, suppl;
abstr 5045.
(11) Leamon, C. P. (2008) Folate-targeted drug strategies for the
treatment of cancer. Curr. Opin. Investig. Drugs 9, 1277−86.
(12) Vlahov, I. R., Santhapuram, H. K., You, F., Wang, Y., Kleindl, P.
J., Hahn, S. J., Vaughn, J. F., Reno, D. S., and Leamon, C. P. (2010)
Carbohydrate-based synthetic approach to control toxicity profiles of
folate-drug conjugates. J. Org. Chem. 75, 3685−91.
(13) Leamon, C. P., Pastan, I., and Low, P. S. (1993) Cytotoxicity of
folate-Pseudomonas exotoxin conjugates toward tumor cells. Con-
tribution of translocation domain. J. Biol. Chem. 268, 24847−54.
(14) Vlahov, I. R., and Leamon, C. P. (2012) Engineering folate-drug
conjugates to target cancer: from chemistry to clinic. Bioconjugate
Chem 23, 1357−69.
(15) Xu, L., Vlahov, I. R., Leamon, C. P., Santhapuram, H. K. R., and
Li, C. H. (2005) Synthesis, purification, and uses of pteroic acid and
derivatives and conjugates thereof. US Patent application number
PCT/US2006/009153, filed March 14, 2006.
(16) Leamon, C. P., Reddy, J. A., Klein, P. J., Vlahov, I. R., Dorton,
R., Bloomfield, A., Nelson, M., Westrick, E., Parker, N., Bruna, K.,
Vetzel, M., Gehrke, M., Nicoson, J. S., Messmann, R. A., LoRusso, P.
M., and Sausville, E. A. (2011) Reducing undesirable hepatic clearance
of a tumor-targeted vinca alkaloid via novel saccharopeptidic
modifications. J. Pharmacol. Exp. Ther. 336, 336−43.
(17) Leamon, C. P., Reddy, J. A., Vlahov, I. R., Kleindl, P. J., Vetzel,
M., and Westrick, E. (2006) Synthesis and biological evaluation of
EC140: A novel folate-targeted vinca alkaloid conjugate. Bioconjugate
Chem. 17, 1226−32.
(18) Jiang, L., Zeng, X., Wang, Z., and Chen, Q. (2009) Cell line
cross-contamination: KB is not an oral squamous cell carcinoma cell
line. European Journal of Oral Sciences 117, 90−1.
568
dx.doi.org/10.1021/bc400441s | Bioconjugate Chem. 2014, 25, 560−568